MAREVAN for Atrial fibrillation: Side Effects & Safety Data
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
There are 5 adverse event reports in the FDA FAERS database where MAREVAN was used for Atrial fibrillation.
Most Reported Side Effects for MAREVAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Acute myocardial infarction | 5 | 45.5% | 5 | 4 |
| Aortic valve stenosis | 5 | 45.5% | 5 | 4 |
| Cardiac failure | 5 | 45.5% | 5 | 4 |
| Hyperkalaemia | 5 | 45.5% | 5 | 4 |
| International normalised ratio increased | 5 | 45.5% | 5 | 4 |
| Renal failure | 5 | 45.5% | 5 | 4 |
Other Drugs Used for Atrial fibrillation
RIVAROXABAN (52,584)
DABIGATRAN ETEXILATE (20,492)
APIXABAN (10,500)
AMIODARONE (9,083)
WARFARIN (8,680)
EDOXABAN (3,855)
ASPIRIN (2,993)
DOFETILIDE (2,439)
PRADAXA (2,325)
METOPROLOL (1,542)